Your browser doesn't support javascript.
loading
Masking by hypokalemia-primary aldosteronism with undetectable aldosterone.
Boyle, Rebecca A; Baker, Jessica E; Charu, Vivek; Rainey, William E; Bhalla, Vivek.
Afiliação
  • Boyle RA; Stanford Hypertension Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Baker JE; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Charu V; Stanford HealthCare, Stanford Hospital, Stanford, CA, USA.
  • Rainey WE; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
  • Bhalla V; Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Clin Kidney J ; 14(4): 1269-1271, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33841871
ABSTRACT
Primary aldosteronism is the most common cause of secondary hypertension; however, the dynamic regulation of aldosterone by potassium is less well studied and current diagnostic recommendations are imprecise. We describe a young man who presented with resistant hypertension and severe hypokalemia. The workup initially revealed undetectable aldosterone despite acute potassium repletion. Chronic potassium supplementation eventually uncovered hyperaldosteronism. In situ genetic studies revealed a gain-of-function KCNJ5 mutation within an aldosterone-producing adenoma that was clinically responsive to changes in extracellular potassium. We highlight a unique presentation of Conn's syndrome and discuss the implications for the molecular mechanisms of potassium regulation of aldosterone.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article